SCHEMBL4563905

SCHEMBL4563905

CCC(N(C(=O)NN)C(=O)c1ccccc1-c1ccccc1)(C(F)(F)F)C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TACR1 P25103 2/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ BCAT2 O15382 1/20 0.39
▸ SCN1A P35498 3/20 0.38
▸ SCN2A Q99250 3/20 0.38
▸ SCN3A Q9NY46 3/20 0.38
▸ ABCB1 P08183 1/20 0.37
▸ CHRNB2 P17787 2/20 0.36
▸ CHRNB4 P30926 2/20 0.36
▸ CHRNA3 P32297 2/20 0.36
▸ CHRNA4 P43681 2/20 0.36
▸ SLC6A4 P31645 2/20 0.36
▸ SLC6A3 Q01959 1/20 0.36
▸ HCRTR1 O43613 2/20 0.35
▸ HCRTR2 O43614 2/20 0.35
▸ HTT P42858 1/20 0.35
▸ LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4563907 0.74 MEN1 (0.46) TACR1ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL1895537 0.74 ABCB1 (0.50) TACR1ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL28815916 0.71 BCAT2 (0.54) TACR1ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL2484726 0.70 MEN1 (0.61) TACR1ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL1826396 0.68 CHRNB2 (0.65) ALDH1A1MEN1KMT2ASMN1; SMN2BCAT2
SCHEMBL30345390 0.68 CHRNB2 (0.65) ALDH1A1MEN1KMT2ASMN1; SMN2BCAT2
SCHEMBL3629780 0.67 MEN1 (0.66) TACR1ALDH1A1MEN1KMT2ASMN1; SMN2
Biphenyl SCHEMBL27596494 0.67 CHRNB2 (0.62) ALDH1A1MEN1KMT2ASMN1; SMN2BCAT2
SCHEMBL8696618 0.66 KMT2A (0.71) TACR1ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL14134492 0.66 MEN1 (0.58) TACR1ALDH1A1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2124921-A2 SULFONYL SEMICARBAZIDES, CARBONYL SEMICARBAZIDES, SEMICARBAZIDES AND UREAS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING INFECTIONS ASSOCIATED WITH ARENAVIRUSES SIGA TECHNOLOGIES, INC. (US) 2009-12-02 — — EP disclosed
WO-2008147474-A2 SULFONYL SEMICARBAZIDES, CARBONYL SEMICARBAZIDES, SEMICARBAZIDES AND UREAS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING INFECTIONS ASSOCIATED WITH ARENAVIRUSES SIGA TECHNOLOGIES, INC. (US) 2008-12-04 — — WO disclosed
Send feedback